The use of CXCL13 as an adjunctive test for patients who tested HIV-negative has been shown to be valuable (22), with significantly elevated levels of CXCL13 in the CSF compared with the serum, indicating intrathecal CXCL13 production in patients with neurosyphilis (21, 25). This evidence concerns the gene CXCL13 and neurosyphilis.